AuMega Metals Ltd. (AUM) Insider Trades
TSXV: AUM · Gold · Advanced Exploration stage
- Market cap$50.9M
- Share price$0.035
- 52-week range$0.025 – $0.065
- Shares outstanding1,455,507,299
- ExchangeTSXV
- Websiteaumegametals.com
- Company Overview
- Interactive Economic Study
- Mining Data
- News
- Financials
- Management Team
- Insider Sales
- SEDAR+ Filings
AuMega Metals Ltd. insider trades (SEDI)
54 insider filings on SEDI; the latest 50 are shown.
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-14 | Open Market Acquisition | 50,000,000 | $0.028 | $1.4M | |
| 2026-06-30 | Carol Marinkovich Executive Director & Company Secretary | Other Derivative Disposition | -300,582 | — | — |
| 2026-06-30 | Carol Marinkovich Executive Director & Company Secretary | Derivative Acquisition Under Employee Benefit Plan | 1,620,000 | $0.030 | $48K |
| 2026-06-30 | Sam Pazuki MD, CEO & Executive Director | Derivative Acquisition Under Employee Benefit Plan | 3,850,000 | $0.028 | $108K |
| 2026-06-30 | Ryan Finkelstein Chief Financial Officer | Derivative Acquisition Under Employee Benefit Plan | 820,000 | $0.282 | $231K |
| 2026-06-30 | Ryan Finkelstein Chief Financial Officer | Other Derivative Disposition | -18,871 | — | — |
| 2026-06-30 | Ryan Finkelstein Chief Financial Officer | Derivative Exercise and Retained Stock | 227,500 | — | — |
| 2026-06-30 | James Carr Withall Independent Non-Executive Director | Derivative Acquisition Under Employee Benefit Plan | 1,408,546 | $0.282 | $397K |
| 2026-06-30 | Derivative Acquisition Under Employee Benefit Plan | 357,144 | $0.282 | $101K | |
| 2026-06-12 | Justin Osborne Independent Non-Executive Chairman | Derivative Exercise and Retained Stock | 824,175 | — | — |
| 2026-06-12 | Derivative Exercise and Retained Stock | 415,512 | — | — | |
| 2026-05-22 | Open Market Disposition | -3,847,000 | $0.026 | $101K | |
| 2026-04-21 | Sam Pazuki MD, CEO & Executive Director | Other Derivative Disposition | -4,322,341 | — | — |
| 2026-04-21 | Sam Pazuki MD, CEO & Executive Director | Other Derivative Disposition | -1,474,568 | — | — |
| 2026-04-16 | James Carr Withall Independent Non-Executive Director | Other Derivative Acquisition | 350,000 | — | — |
| 2026-04-16 | James Carr Withall Independent Non-Executive Director | Open Market Acquisition | 350,000 | $0.029 | $10K |
| 2026-04-16 | Open Market Acquisition | 1,000,000 | $0.029 | $29K | |
| 2026-04-15 | Sam Pazuki MD, CEO & Executive Director | Open Market Acquisition | 851,064 | $0.034 | $29K |
| 2026-04-15 | Private Acquisition | 190,998,412 | $0.029 | $5.6M | |
| 2026-04-15 | Other Derivative Acquisition | 190,998,412 | $0.040 | $7.6M | |
| 2026-04-15 | Other Derivative Acquisition | 1,000,000 | — | — | |
| 2026-04-15 | Open Market Acquisition | 75,000,000 | $0.029 | $2.1M | |
| 2026-04-15 | Private Acquisition | 65,625,000 | — | — | |
| 2026-04-14 | Private Acquisition | 190,998,412 | $0.029 | $5.6M | |
| 2026-04-14 | Open Market Acquisition | 135,000,000 | $0.029 | $3.9M | |
| 2026-03-05 | Other Derivative Acquisition | 98,376,589 | $0.040 | $3.9M | |
| 2026-03-05 | Private Acquisition | 98,376,589 | $0.040 | $3.9M | |
| 2025-12-10 | Justin Osborne Independent Non-Executive Chairman | Open Market Acquisition | 1,000,000 | $0.025 | $25K |
| 2025-12-10 | Open Market Acquisition | 300,000 | $0.030 | $9K | |
| 2025-12-05 | Open Market Acquisition | 200,000 | $0.032 | $6K | |
| 2025-12-04 | Sam Pazuki MD, CEO & Executive Director | Open Market Acquisition | 350,000 | $0.024 | $8K |
| 2025-12-03 | Sam Pazuki MD, CEO & Executive Director | Open Market Acquisition | 957,583 | $0.028 | $27K |
| 2025-12-03 | James Carr Withall Independent Non-Executive Director | Open Market Acquisition | 500,000 | $0.029 | $14K |
| 2025-10-23 | Sam Pazuki MD, CEO & Executive Director | Derivative Exercise and Retained Stock | 1,083,209 | $0.000 | $77 |
| 2025-09-19 | Open Market Acquisition | 10,312,961 | $0.025 | $255K | |
| 2025-07-18 | Carol Marinkovich Executive Director & Company Secretary | Derivative Exercise and Retained Stock | 540,882 | — | — |
| 2025-07-18 | Sam Pazuki MD, CEO & Executive Director | Derivative Exercise and Retained Stock | 1,083,209 | $0.039 | $42K |
| 2025-07-07 | Michael Bethel Skead President | Derivative Acquisition Under Employee Benefit Plan | 6,000,000 | $0.040 | $242K |
| 2025-07-04 | Carol Marinkovich Executive Director & Company Secretary | Other Derivative Disposition | -1,027,965 | — | — |
| 2025-07-04 | Carol Marinkovich Executive Director & Company Secretary | Other Derivative Acquisition | 553,782 | — | — |
| 2025-07-04 | Carol Marinkovich Executive Director & Company Secretary | Derivative Exercise and Retained Stock | 540,882 | $0.020 | $11K |
| 2025-07-04 | Carol Marinkovich Executive Director & Company Secretary | Derivative Acquisition Under Employee Benefit Plan | 1,882,860 | — | — |
| 2025-07-04 | Sam Pazuki MD, CEO & Executive Director | Derivative Acquisition Under Employee Benefit Plan | 4,999,424 | — | — |
| 2025-07-04 | Sam Pazuki MD, CEO & Executive Director | Other Derivative Acquisition | 2,999,654 | — | — |
| 2025-07-04 | Sam Pazuki MD, CEO & Executive Director | Derivative Acquisition Under Employee Benefit Plan | 2,999,655 | $0.040 | $121K |
| 2025-07-04 | Sam Pazuki MD, CEO & Executive Director | Other Derivative Acquisition | 4,999,424 | — | — |
| 2025-07-04 | Sam Pazuki MD, CEO & Executive Director | Other Derivative Disposition | -4,366,305 | — | — |
| 2025-07-04 | Sam Pazuki MD, CEO & Executive Director | Other Derivative Acquisition | 5,999,309 | — | — |
| 2025-07-04 | Ryan Finkelstein Chief Financial Officer | Derivative Acquisition Under Employee Benefit Plan | 559,935 | $0.040 | $23K |
| 2025-07-04 | Ryan Finkelstein Chief Financial Officer | Other Derivative Acquisition | 559,935 | — | — |